Investing
Ellington Financial Inc.·Cash Flow Statement·29 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Payments For Securities Purchased Under Agreements To Resell | $5.6B | $11.1B | $16.7B | $16.4B | $16.6B | $14.4B | $16.8B | $17B |
| Proceeds From Securities Purchased Under Agreements To Resell | $5.7B | $10.8B | $16.7B | $16.4B | $16.6B | $14.4B | $16.7B | $17B |
| Net cash from investing activities | $76.3M | -$576.2M | -$621.4M | -$633.8M | -$495.7M | -$1B | -$1.9B | -$1.9B |
| Change in mortgage loans | $708.7M | $558.5M | $596.4M | $553.7M | $543.1M | $626.5M | $565.9M | $565.7M |
| Purchases of investments | $238.8M | $139.6M | $302.3M | $252.2M | $270.9M | $268.7M | $185.9M | $347.9M |
| Proceeds from securities sold short | $40.8M | $272.7M | $545.1M | $424.1M | $181M | $233.1M | $64.9M | $324.4M |
| Repurchase Of Securities Sold Short, Investing Activities | $154.1M | $24.4M | $542.8M | $459.5M | $183.4M | $263.9M | $26.6M | $297M |
| Sales of short-term available-for-sale investments | $201.5M | $214.7M | $556.4M | $276.9M | $289.3M | $301M | $95.6M | $193.1M |
| Sale of investments | $201.5M | $214.7M | $556.4M | $276.9M | $289.3M | $301M | $95.6M | $193.1M |
| Proceeds from maturities/sales of investments | $201.5M | $214.7M | $556.4M | $276.9M | $289.3M | $301M | $95.6M | $193.1M |
| Dividend Received from Consumer Healthcare JV | $127.3M | $38.8M | $60.5M | $88.1M | $68.9M | $201.8M | $141.4M | $157M |
| Distributions from DIRECTV in Excess of Earnings | $127.3M | $38.8M | $60.5M | $88.1M | $68.9M | $201.8M | $141.4M | $157M |
| Loans | $121.3M | $20.4M | $70M | $76.2M | $381.2M | $22.7M | $30.9M | $104M |
| Payments for Derivative Instruments (Investing) | $40.7M | $98M | $72.7M | $106.7M | $89.6M | $103.7M | $58.6M | $88.5M |
| Payments for Hedge, Investing Activities | $40.7M | $98M | $72.7M | $106.7M | $89.6M | $103.7M | $58.6M | $88.5M |
| Proceeds from Derivative Instrument Investing Activities | $46.6M | $74.2M | $95M | $111.6M | $76.8M | $100.2M | $48.6M | $79M |
| Investing Cash Flows from Derivatives | $46.6M | $74.2M | $95M | $111.6M | $76.8M | $100.2M | $48.6M | $79M |
| Proceeds from FHA insurance claims and other receivables on HECM loans | $12.7M | $20.6M | $22.5M | $24.6M | $29.5M | $34.7M | $45.4M | $60.8M |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale | $50.2M | $30.9M | $42.4M | $40.4M | $45M | $42.4M | $40.4M | $49.9M |
| Payments To Brokers, Investing Activities | -$11.5M | — | — | $430K | $22.3M | $5.2M | — | -$29.3M |
| Payments to Acquire Equity Method Investments | $38.3M | $35.7M | $30.3M | $62.3M | $75.2M | $90M | $5.2M | $24.7M |
| Purchases of equity securities | $38.3M | $35.7M | $30.3M | $62.3M | $75.2M | $90M | $5.2M | $24.7M |
| Proceeds from disposition of real estate owned | $7.6M | $15.7M | $4.8M | $10.8M | $27.8M | $17.6M | $2.4M | $15.9M |
| Due from brokers, net | — | $6.1M | $2.6M | -$26M | -$172K | — | — | $8.2M |
| Proceeds from Sale of Forward MSR-related Investments | $7M | $7.7M | $82.6M | $8M | $6.1M | $7M | $2M | $7.3M |
| Capital expenditures | $0 | $0 | $0 | $0 | — | — | — | -$168K |
| Payments for Capital Improvements | $0 | $0 | $0 | $0 | — | — | — | -$168K |
| Cash acquired from acquisition | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Cash acquired from acquisition | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |